Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Protein tyrosine phosphatase type IVA, member 1 pseudogene is a genomic DNA sequence homologous to the functional PTP4A1 gene, but it does not encode a functional protein product. Functional protein tyrosine phosphatase type IVA 1 (PTP4A1) is an enzyme involved in cell signaling, control of cell proliferation, migration, and cancer progression, but the pseudogene variant is generally transcriptionally silent and does not participate in these processes. Pseudogenes often arise from gene duplication or retrotransposition events and serve as evolutionary remnants without a direct role in cellular function[1][3][4]. The gene corresponding to ENSG00000258638 is explicitly a pseudogene, and not a therapeutic target. There is no evidence of protein expression, disease association, drug targeting, or biomarker utility for this pseudogene. The functional gene, PTP4A1, is a known enzyme and cancer-related target, but the pseudogene discussed here is not the same and should not be conflated with the active protein or gene[1][3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Protein tyrosine phosphatase type IVA, member 1 pseudogene.